Cancer patients' experiences with immune checkpoint modulators: A qualitative study.
Ala-Leppilampi K, Baker NA, McKillop C, Butler MO, Siu LL, Spreafico A, Abdul Razak AR, Joshua AM, Hogg D, Bedard PL, Leighl N, Oza AM, Parsons JA, Hansen AR.
Ala-Leppilampi K, et al.
Cancer Med. 2020 May;9(9):3015-3022. doi: 10.1002/cam4.2940. Epub 2020 Mar 2.
Cancer Med. 2020.
PMID: 32119767
Free PMC article.